COUMADIN Drug Patent Profile
✉ Email this page to a colleague
When do Coumadin patents expire, and when can generic versions of Coumadin launch?
Coumadin is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in COUMADIN is warfarin sodium. There are twenty-two drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the warfarin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Coumadin
A generic version of COUMADIN was approved as warfarin sodium by TARO on July 15th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COUMADIN?
- What are the global sales for COUMADIN?
- What is Average Wholesale Price for COUMADIN?
Summary for COUMADIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 134 |
| Clinical Trials: | 132 |
| Drug Prices: | Drug price information for COUMADIN |
| Drug Sales Revenues: | Drug sales revenues for COUMADIN |
| What excipients (inactive ingredients) are in COUMADIN? | COUMADIN excipients list |
| DailyMed Link: | COUMADIN at DailyMed |
Recent Clinical Trials for COUMADIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Laval University | Phase 2 |
| Helm Vision Group | Phase 1 |
| Mirati Therapeutics Inc. | Phase 1 |
US Patents and Regulatory Information for COUMADIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | COUMADIN | warfarin sodium | INJECTABLE;INJECTION | 009218-024 | Feb 7, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bristol Myers Squibb | COUMADIN | warfarin sodium | TABLET;ORAL | 009218-025 | Nov 18, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bristol Myers Squibb | COUMADIN | warfarin sodium | TABLET;ORAL | 009218-022 | Mar 1, 1990 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bristol Myers Squibb | COUMADIN | warfarin sodium | TABLET;ORAL | 009218-005 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
